Skyepharma Names CFO and Executive Director

News
Article

Andrew Derodra will join Skyepharma in the fourth quarter of 2013.

The drug-delivery company Skypharma has appointed Andrew Derodra as CFO and an executive director, effective in the fourth quarter of 2013.

Derodra joins Skyepharma from Tate & Lyle, where he had been group vice-president, finance and control, since 2011. He has spent 23 years working in senior finance roles for various companies, including SABMiller, Diageo, British Airways, and Reed Elsevier.

Source: Skypharma

Recent Videos
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content